HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Sofia Molonia Selected Research

Palmitic Acid (Hexadecanoic Acid)

10/2022A pinitol-rich Glycyrrhiza glabra L. leaf extract as functional supplement with potential in the prevention of endothelial dysfunction through improving insulin signalling.
9/2022Effects of a pinitol-rich Glycyrrhiza glabra L. leaf extract on insulin and inflammatory signaling pathways in palmitate-induced hypertrophic adipocytes.
12/2021In Vitro Effects of Cyanidin-3-O-Glucoside on Inflammatory and Insulin-Sensitizing Genes in Human Adipocytes Exposed to Palmitic Acid.
10/2020Cyanidin-3-O-glucoside protects intestinal epithelial cells from palmitate-induced lipotoxicity.
1/2020Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes.
7/2019Anthocyanins ameliorate palmitate-induced inflammation and insulin resistance in 3T3-L1 adipocytes.
3/2017Cyanidin-3-O-glucoside ameliorates palmitate-induced insulin resistance by modulating IRS-1 phosphorylation and release of endothelial derived vasoactive factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Sofia Molonia Research Topics

Disease

9Inflammation (Inflammations)
09/2022 - 12/2016
6Insulin Resistance
10/2022 - 03/2017
2Hypertrophy
09/2022 - 07/2019
2Neoplasms (Cancer)
03/2022 - 07/2021
2COVID-19
08/2021 - 01/2021
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2020 - 12/2016
2Obesity
10/2020 - 01/2020
1Liver Neoplasms (Liver Cancer)
03/2022
1Intestinal Diseases (Diseases, Intestinal)
01/2022
1Thrombosis (Thrombus)
08/2021
1Noncommunicable Diseases
01/2020
1Glioma (Gliomas)
03/2019
1Multiple Myeloma
03/2018

Drug/Important Bio-Agent (IBA)

7Palmitic Acid (Hexadecanoic Acid)IBA
10/2022 - 03/2017
5Anthocyanins (Anthocyanin)IBA
12/2021 - 03/2017
3Nonesterified Fatty Acids (NEFA)IBA
10/2022 - 03/2017
3CurcuminIBA
07/2021 - 03/2018
2Proteins (Proteins, Gene)FDA Link
08/2021 - 03/2017
2CytokinesIBA
08/2021 - 10/2020
2Insulin (Novolin)FDA Link
01/2020 - 03/2017
2PalmitatesIBA
07/2019 - 03/2017
1LipidsIBA
09/2022
1pinitolIBA
09/2022
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2022
1Glycyrrhetinic Acid (Po 12)IBA
03/2022
1Biocompatible Materials (Biomaterials)IBA
03/2022
1PolyphenolsIBA
01/2022
1PhytochemicalsIBA
01/2022
1EnzymesIBA
12/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1HexokinaseIBA
12/2021
1Plasminogen Activator Inhibitor 1IBA
08/2021
1Silybin (Lagosa)IBA
08/2021
1AnticoagulantsIBA
08/2021
1Hemostatics (Antihemorrhagics)IBA
08/2021
1Peptides (Polypeptides)IBA
08/2021
1Interleukin-6 (Interleukin 6)IBA
08/2021
1Bleaching AgentsIBA
08/2021
1Biological ProductsIBA
07/2021
1ResveratrolIBA
07/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1AntioxidantsIBA
01/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
07/2019
1Messenger RNA (mRNA)IBA
07/2019
13-hydroxy-5-estrane-17-carbonitrile (ACN)IBA
07/2019
1AdiponectinIBA
07/2019
1Phosphotransferases (Kinase)IBA
07/2019
1Paclitaxel (Taxol)FDA LinkGeneric
03/2019
1carfilzomibIBA
03/2018
1Vasodilator Agents (Vasodilators)IBA
03/2017
1Vasoconstrictor AgentsIBA
03/2017
1Endothelin-1 (Endothelin 1)IBA
03/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2017
1FlavonoidsIBA
12/2016
1NF-kappa B (NF-kB)IBA
12/2016

Therapy/Procedure

3Therapeutics
03/2022 - 03/2019
1Radiotherapy
03/2022
1Drug Therapy (Chemotherapy)
03/2022
1Combination Drug Therapy (Combination Chemotherapy)
07/2021